# BANDIT-077 Stage 3 PM Review

contract_version: 1
work_item: BANDIT-077
stage: stage3_pm_acceptance
reviewer: codex_pm
recorded_at: 2026-06-08T17:11:24Z
verdict: pass

## Scope And Spec Alignment

- verdict: pass
- evidence: `docs/work/BANDIT-077/brief.md`, `docs/work/BANDIT-077/red-evidence.md`, `docs/work/BANDIT-077/writer-report.md`, `docs/work/BANDIT-077/implementation-evidence.md`, `node ./bin/bandit.mjs spec-to-evidence validate BANDIT-077 --json`

The implementation satisfies the bounded Spec-To-Evidence Traceability Matrix
chore. It adds a policy, template, public validation command, deterministic
derived report, fail-closed diagnostics for weak mappings, review-template
traceability fields, and real `BANDIT-077` traceability matrix validation.

## Clean-Code Review

- verdict: pass
- evidence: `CLEAN_CODE.md`, `src/state/spec-to-evidence-traceability.ts`, `src/commands/spec-to-evidence.ts`

Clean-code posture is acceptable for Stage 3:

- Spec alignment: behavior maps to the approved brief and RED evidence.
- Small surface area: source changes are limited to one state module, one
  command module, CLI registration, one policy, and two templates.
- Simple design: policy/brief/matrix loading, entry evaluation, diagnostics,
  and rendering are separated.
- Explicit state: all workflow authority remains in repo artifacts and command
  output; traceability is derived only.
- Failure clarity: missing policy, malformed matrix, missing mappings, vague
  evidence, unsupported evidence, implementation-detail misuse, and vague
  dispositions fail closed with specific diagnostics.
- No role erosion: Claude did not edit Test Writer-owned surfaces.
- Improvement capture: no new durable improvement chore is required from Stage
  3; the one implementation gap was repaired immediately through Test Writer
  RED repair plus Claude source repair.

## Model-Family Separation

- verdict: pass
- evidence: `docs/work/BANDIT-077/red-evidence.md`, `docs/work/BANDIT-077/writer-report.md`, `docs/role-runs/BANDIT-077/stage3-implementation.json`

Codex authored Stage 2 RED evidence. Stage 3 implementation ran through the
Claude-family implementation-writer path. Verification escalation and PM
acceptance are performed by Codex PM, not Claude.

## Test-Surface Boundary

- verdict: pass
- evidence: `git diff --name-only`, `docs/role-runs/BANDIT-077/stage3-implementation.json`, `docs/work/BANDIT-077/writer-report.md`

Claude's writer report and role-run manifest record `test_surfaces_edited: []`.
The Test Writer-owned repair test and
`docs/work/BANDIT-077/spec-to-evidence-traceability.json` were created by Codex
Test Writer/PM, not by the Claude implementation writer. Claude's bounded
repair edited source behavior only.

## Verification

- verdict: pass
- evidence:
  - `node --test test/spec-to-evidence-traceability.test.mjs` - pass, 7/7.
  - `node ./bin/bandit.mjs spec-to-evidence validate BANDIT-077 --json` - pass.
  - `npm run typecheck` - pass.
  - `npm run bandit -- validate` - pass.
  - `node ./bin/bandit.mjs coordination validate BANDIT-077` - pass.
  - `npm test` - pass, 574/574.
  - `git diff --check` - pass.

## Disposition

Stage 3 is accepted. The next required action is Stage 4 review: CodeRabbit or
provider-timeout evidence, Local Qwen through `.bandit/reviewers/local-qwen.json`
and `bin/omlx-chat-completions.mjs`, risk classification, supply-chain gate,
review-subject hash, traceability-quality review, and aggregate review evidence
before Stage 5 landing.
